TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Odeum Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
205
|
226 | |
| Financial expenses |
0
|
4 | |
| Earnings before taxes |
-446
|
-334 | |
| EBITDA |
-374
|
-277 | |
| Total assets |
13,524
|
14,935 | |
| Current assets |
9,943
|
11,183 | |
| Current liabilities |
377
|
927 | |
| Equity capital |
12,960
|
13,703 | |
| - share capital |
95
|
98 | |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
95.8%
|
91.8% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-217.6%
|
-147.8% | |
| Return on assets (ROA) |
-3.3%
|
-2.2% | |
| Current ratio |
2637.4%
|
1206.4% | |
| Return on equity (ROE) |
-3.4%
|
-2.4% | |
| Change turnover |
-15
|
82 | |
| Change turnover % |
9%
|
-7%
|
57% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.